| SCHOTT PHARMA INH O.N. |
| Deutschland |
| Industrie |
| DE000A3ENQ51 / A3ENQ5 |
| 1SXP (Frankfurt) |
| FRA:1SXP, ETR:1SXP, 1SXP:GR |
| SDAX |
| https://www.schott.com/ |
|
SCHOTT Pharma AG & Co. KGaA is a leading provider of drug containment and delivery solutions, specializing in primary packaging for injectable pharmaceuticals. Headquartered in Mainz, Germany, and part of SCHOTT AG owned by the Carl Zeiss Foundation,..
>Volltext.. |
| 3474.64 Mio. EUR |
| 3451.95 Mio. EUR |
| 1001.79 Mio. EUR |
| 241.39 Mio. EUR |
| 134.48 Mio. EUR |
| 0.89 EUR |
| - |
| 24.5 Mio. EUR |
| 190.1 Mio. EUR |
| 0.06 |
| 4.28% |
| -7.01% |
| 0.18 EUR |
| 0.78% |
| 0.78% |
| 04.02.26 - 0.18€ 05.02.25 - 0.16€ >weitere anzeigen... |
| - |
| SCHOTT PHARMA |
| 15.09.26 |
|
||||
|
||||
|
||||
|
||||
|